Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: A systematic review

Hepatobiliary and Pancreatic Diseases International

Volumn 13, Issue 5, 2014, Pages 474-481

  Ahmad, Jawad ^a   Grimes, Nathan ^a   Farid, Shahid ^b   Morris Stiff, Gareth ^c  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b KETTERING GENERAL HOSPITAL   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Glasgow prognostic score; modified Glasgow prognostic score; neutrophil lymphocyte ratio; pancreatic ductal adenocarcinoma; platelet lymphocyte ratio; prognostic nutrition index

Indexed keywords

CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; FOLLOW UP; HUMAN; INFLAMMATION; NEUTROPHIL LYMPHOCYTE RATIO; ONCOLOGICAL PARAMETERS; PANCREAS ADENOCARCINOMA; PLATELET LYMPHOCYTE RATIO; PRACTICE GUIDELINE; PROGNOSTIC NUTRITION INDEX; REVIEW; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; ADENOCARCINOMA; BLOOD; LYMPHOCYTE COUNT; METABOLISM; NEUTROPHIL; NUTRITIONAL STATUS; PANCREAS TUMOR; PROGNOSIS; SEVERITY OF ILLNESS INDEX; THROMBOCYTE COUNT;

C REACTIVE PROTEIN; SERUM ALBUMIN;

ADENOCARCINOMA; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION; LYMPHOCYTE COUNT; NEUTROPHILS; NUTRITIONAL STATUS; PANCREATIC NEOPLASMS; PLATELET COUNT; PROGNOSIS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX;

EID: 84936771532     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(14)60284-8     Document Type: Review

References (56)

1. S Raimondi, P Maisonneuve, AB Lowenfels Epidemiology of pancreatic cancer: an overview Nat Rev Gastroenterol Hepatol 6 2009 699 708
2. D Li, K Xie, R Wolff, JL Abbruzzese Pancreatic cancer Lancet 363 2004 1049 1057
3. A Richter, M Niedergethmann, JW Sturm, D Lorenz, S Post, M Trede Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience World J Surg 27 2003 324 329
4. JM Winter, JL Cameron, KA Campbell, MA Arnold, DC Chang, J Coleman et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience J Gastrointest Surg 10 2006 1199 1211
5. C Bosetti, P Bertuccio, E Negri, C La Vecchia, MP Zeegers, P Boffetta Pancreatic cancer: overview of descriptive epidemiology Mol Carcinog 51 2012 3 13
6. DC McMillan The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer Cancer Treat Rev 39 2013 534 540
7. Z Mohamed, DJ2 Pinato, FA3 Mauri, KW4 Chen, PM4 Chang, R2 Sharma Inflammation as a validated prognostic determinant in carcinoma of unknown primary site Br J Cancer 110 2014 208 213
8. DF Stroup, JA Berlin, SC Morton, I Olkin, GD Williamson, D Rennie et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
9. J Singh Critical appraisal skills programme. [2013-09-01] Available from: http://www.jpharmacol.com/text.asp?2013/4/1/76/107697
10. D Moher, A Liberati, J Tetzlaff, DG Altman, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 2010 336 341
11. NB Jamieson, M Mohamed, KA Oien, AK Foulis, EJ Dickson, CW Imrie et al. The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma Ann Surg Oncol 19 2012 3581 3590
12. M Stotz, A Gerger, F Eisner, J Szkandera, H Loibner, AL Ress et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer Br J Cancer 109 2013 416 421
13. DS Wang, HY Luo, MZ Qiu, ZQ Wang, DS Zhang, FH Wang et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer Med Oncol 29 2012 3092 3100
14. P Glen, NB Jamieson, DC McMillan, R Carter, CW Imrie, CJ McKay Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer Pancreatology 6 2006 450 453
15. M La Torre, G Nigri, M Cavallini, P Mercantini, V Ziparo, G Ramacciato The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma Ann Surg Oncol 19 2012 2917 2923
16. M Shimoda, M Katoh, J Kita, T Sawada, K Kubota The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer Chemotherapy 56 2010 501 506
17. M Aliustaoglu, A Bilici, M Seker, F Dane, M Gocun, V Konya et al. The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer Hepatogastroenterology 57 2010 640 645
18. X An, PR Ding, YH Li, FH Wang, YX Shi, ZQ Wang et al. Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer Biomarkers 15 2010 516 522
19. I Bhatti, O Peacock, G Lloyd, M Larvin, RI Hall Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio Am J Surg 200 2010 197 203
20. EJ Clark, S Connor, MA Taylor, KK Madhavan, OJ Garden, RW Parks Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma HPB (Oxford) 9 2007 456 460
21. G Garcea, N Ladwa, CP Neal, MS Metcalfe, AR Dennison, DP Berry Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma World J Surg 35 2011 868 872
22. NB Jamieson, SM Denley, J Logue, DJ MacKenzie, AK Foulis, EJ Dickson et al. A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma Ann Surg Oncol 18 2011 2318 2328
23. P Sanjay, RS de Figueiredo, H Leaver, S Ogston, C Kulli, FM Polignano et al. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma JOP 13 2012 199 204
24. RA Smith, L Bosonnet, M Raraty, R Sutton, JP Neoptolemos, F Campbell et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma Am J Surg 197 2009 466 472
25. M Kanda, T Fujii, Y Kodera, S Nagai, S Takeda, A Nakao Nutritional predictors of postoperative outcome in pancreatic cancer Br J Surg 98 2011 268 274
26. CJ McKay, P Glen, DC McMillan Chronic inflammation and pancreatic cancer Best Pract Res Clin Gastroenterol 22 2008 65 73
27. CS Roxburgh, DC McMillan Role of systemic inflammatory response in predicting survival in patients with primary operable cancer Future Oncol 6 2010 149 163
28. FA Mahmoud, NI Rivera The role of C-reactive protein as a prognostic indicator in advanced cancer Curr Oncol Rep 4 2002 250 255
29. HH Chen, IH Chen, CT Liao, FC Wei, LY Lee, SF Huang Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study Clin Otolaryngol 36 2011 147 153
30. JS Falconer, KC Fearon, JA Ross, R Elton, SJ Wigmore, OJ Garden et al. Acute-phase protein response and survival duration of patients with pancreatic cancer Cancer 75 1995 2077 2082
31. KC Fearon, MD Barber, JS Falconer, DC McMillan, JA Ross, T Preston Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia World J Surg 23 1999 584 588
32. F Colotta, P Allavena, A Sica, C Garlanda, A Mantovani Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 2009 1073 1081
33. NB Jamieson, P Glen, DC McMillan, CJ McKay, AK Foulis, R Carter et al. Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas Br J Cancer 92 2005 21 23
34. F Donskov, M Hokland, N Marcussen, HH Torp Madsen, H von der Maase Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma-results from a randomised phase II trial Br J Cancer 94 2006 218 226
35. TH Price, GS Chatta, DC Dale Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans Blood 88 1996 335 340
36. TR Ulich, J del Castillo, M Keys, GA Granger, RX Ni Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes J Immunol 139 1987 3406 3415
37. F Romano, F Uggeri, S Crippa, G Di Stefano, M Scotti, A Scaini et al. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers J Exp Clin Cancer Res 23 2004 195 200
38. W von Bernstorff, M Voss, S Freichel, A Schmid, I Vogel, C Jöhnk et al. Systemic and local immunosuppression in pancreatic cancer patients Clin Cancer Res 7 2001 925s 932s
39. G Bellone, A Turletti, E Artusio, K Mareschi, A Carbone, D Tibaudi et al. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients Am J Pathol 155 1999 537 547
40. K Suzuki, K Aiura, M Kitagou, S Hoshimoto, S Takahashi, M Ueda et al. Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients Hepatogastroenterology 51 2004 847 853
41. MG Alexandrakis, FH Passam, IA Moschandrea, AV Christo-phoridou, CA Pappa, SA Coulocheri et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis Am J Clin Oncol 26 2003 135 140
42. M Sierzega, B Niekowal, J Kulig, T Popiela Nutritional status affects the rate of pancreatic fistula after distal pancreatectomy: a multivariate analysis of 132 patients J Am Coll Surg 205 2007 52 59
43. I Schwegler, A von Holzen, JP Gutzwiller, R Schlumpf, S Mühlebach, Z Stanga Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer Br J Surg 97 2010 92 97
44. M La Torre, V Ziparo, G Nigri, M Cavallini, G Balducci, G Ramacciato Malnutrition and pancreatic surgery: prevalence and outcomes J Surg Oncol 107 2013 702 708
45. JM Argilés Cancer-associated malnutrition Eur J Oncol Nurs 9 2005 S39 S50
46. P Li, YL Yin, D Li, SW Kim, G Wu Amino acids and immune function Br J Nutr 98 2007 237 252
47. V Lohsiriwat, D Lohsiriwat, W Boonnuch, V Chinswangwatanakul, T Akaraviputh, N Lert-Akayamanee Pre-operative hypoalbuminemia is a major risk factor for postoperative complications following rectal cancer surgery World J Gastroenterol 14 2008 1248 1251
48. AM Ryan, A Hearty, RS Prichard, A Cunningham, SP Rowley, JV Reynolds Association of hypoalbuminemia on the first postoperative day and complications following esophagectomy J Gastrointest Surg 11 2007 1355 1360
49. DY Greenblatt, KJ Kelly, V Rajamanickam, Y Wan, T Hanson, R Rettammel et al. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy Ann Surg Oncol 18 2011 2126 2135
50. LM Forrest, DC McMillan, CS McArdle, WJ Angerson, DJ Dunlop Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer Br J Cancer 90 2004 1704 1706
51. DC McMillan, JE Crozier, K Canna, WJ Angerson, CS McArdle Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer Int J Colorectal Dis 22 2007 881 886
52. AM Al Murri, JM Bartlett, PA Canney, JC Doughty, C Wilson, DC McMillan Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer Br J Cancer 94 2006 227 230
53. D Gomez, S Farid, HZ Malik, AL Young, GJ Toogood, JP Lodge et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg 32 2008 1757 1762
54. MJ Proctor, DC McMillan, DS Morrison, CD Fletcher, PG Horgan, SJ Clarke A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer Br J Cancer 107 2012 695 699
55. J Szkandera, M Stotz, F Eisner, G Absenger, T Stojakovic, H Samonigg et al. External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients PLoS One 8 2013 e78225
56. T Onodera, N Goseki, G Kosaki Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients Nihon Geka Gakkai Zasshi 85 1984 1001 1005